Initiation of ARNi and SGLT2i in Patients With HFrEF
Condition: Heart Failure With Reduced Ejection Fraction Interventions: Drug: Sacubitril-valsartan; Drug: SGLT2 inhibitor Sponsor: Universidade do Porto Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials